share_log

BioDelivery Sciences International Reiterates FY21 Sales Guidance Of $170M-$180M

Benzinga Real-time News ·  May 6, 2021 07:51
BioDelivery Sciences International Reiterates FY21 Sales Guidance Of $170M-$180M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment